首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   18968篇
  免费   1836篇
  国内免费   25篇
耳鼻咽喉   221篇
儿科学   585篇
妇产科学   552篇
基础医学   2496篇
口腔科学   472篇
临床医学   2380篇
内科学   3456篇
皮肤病学   449篇
神经病学   1604篇
特种医学   593篇
外国民族医学   1篇
外科学   2496篇
综合类   368篇
一般理论   23篇
预防医学   2309篇
眼科学   363篇
药学   1283篇
中国医学   20篇
肿瘤学   1158篇
  2022年   133篇
  2021年   287篇
  2020年   196篇
  2019年   326篇
  2018年   383篇
  2017年   316篇
  2016年   330篇
  2015年   377篇
  2014年   479篇
  2013年   746篇
  2012年   996篇
  2011年   1032篇
  2010年   593篇
  2009年   523篇
  2008年   976篇
  2007年   983篇
  2006年   969篇
  2005年   1004篇
  2004年   1018篇
  2003年   965篇
  2002年   879篇
  2001年   441篇
  2000年   433篇
  1999年   413篇
  1998年   232篇
  1997年   224篇
  1996年   171篇
  1995年   170篇
  1994年   131篇
  1993年   153篇
  1992年   278篇
  1991年   270篇
  1990年   291篇
  1989年   259篇
  1988年   232篇
  1987年   193篇
  1986年   248篇
  1985年   209篇
  1984年   188篇
  1983年   175篇
  1982年   145篇
  1981年   140篇
  1980年   157篇
  1979年   180篇
  1978年   158篇
  1977年   144篇
  1976年   120篇
  1975年   145篇
  1974年   157篇
  1973年   155篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
AimsThe aims were to 1) develop the pharmacokinetics model to describe and predict observed tanezumab concentrations over time, 2) test possible covariate parameter relationships that could influence clearance and distribution and 3) assess the impact of fixed dosing vs. a dosing regimen adjusted by body weight.MethodsIndividual concentration–time data were determined from 1608 patients in four phase 3 studies conducted to assess efficacy and safety of intravenous tanezumab. Patients received two or three intravenous doses (2.5, 5 or 10 mg) every 8 weeks. Blood samples for assessment of tanezumab PK were collected at baseline, 1 h post‐dose and at weeks 4, 8, 16 and 24 (or early termination) in all studies. Blood samples were collected at week 32 in two studies. Plasma samples were analyzed using a sensitive, specific, validated enzyme‐linked immunosorbent assay.ResultsA two compartment model with parallel linear and non‐linear elimination processes adequately described the data. Population estimates for clearance (CL), central volume (V 1), peripheral volume (V 2), inter‐compartmental clearance, maximum elimination capacity (VM) and concentration at half‐maximum elimination capacity were 0.135 l day–1, 2.71 l, 1.98 l, 0.371 l day–1, 8.03 μg day–1 and 27.7 ng ml–1, respectively. Inter‐individual variability (IIV) was included on CL, V 1, V 2 and VM. A mixture model accounted for the distribution of residual error. While gender, dose and creatinine clearance were significant covariates, only body weight as a covariate of CL, V 1 and V 2 significantly reduced IIV.ConclusionsThe small increase in variability associated with fixed dosing is consistent with other monoclonal antibodies and does not change risk : benefit.  相似文献   
3.
4.
5.
6.
7.
8.
9.
10.
Several studies have demonstrated that a descending dopaminergic pathway innervates the dorsal and the intermediate gray matter of the spinal cord and have suggested that this pathway is involved in pain modulation and in the control of autonomie functions. Other studies have also demonstrated the presence of dopamine (DA) and DA metabolites as well as of DA receptors in the ventral cord. There is also evidence for the implication of DA in the control of motor functions at the spinal level. The occurrence of a dopaminergic innervation in the ventral horn has been, however, disputed until recently. But recent work has demonstrated that the motoneural cell groups in the ventral horn (lamina IX) are a target for descending dopaminergic fibers. In addition, the possibility that DA is a mediator of primary afferent fibers has also been postulated. Finally, the occurrence of dopaminergic cell bodies has been suggested in the spinal cord. This indicates that DA is probably implicated in a complex manner in spinal functions. In the present paper the possible involvement of DA in sensory and in motor functions at spinal level will be discussed in view of neurochemical observations made in polyarthritic rats, in which pain-related behavior and reduction of locomotor activity associated with a marked decrease in mobility, are observed.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号